Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Lipid and inflammatory biomarker profiles in patients receiving tocilizumab for rheumatoid arthritis: Analysis of five phase 3 clinical trials Genovese, M. C., Smolen, J. S., Emery, P., Jones, G., Lee, J. S., Alecock, E., Kremer, J. M. WILEY-LISS. 2008: S531–S532
View details for Web of Science ID 000259244201247